Filing Details
- Accession Number:
- 0001179110-13-007681
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-03 16:37:48
- Reporting Period:
- 2013-05-01
- Filing Date:
- 2013-05-03
- Accepted Time:
- 2013-05-03 16:37:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1227124 | Paul Goddard | C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-01 | 4,000 | $12.50 | 18,890 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-05-01 | 1,000 | $28.41 | 19,890 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-01 | 3,000 | $92.67 | 16,890 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-05-01 | 1,000 | $93.85 | 15,890 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-05-01 | 800 | $93.02 | 15,090 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-05-01 | 200 | $94.08 | 14,890 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-05-01 | 4,000 | $0.00 | 4,000 | $12.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-05-01 | 1,000 | $0.00 | 1,000 | $28.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,000 | 2017-02-07 | No | 4 | M | Direct | |
| 6,000 | 2015-02-07 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to 10b5-1 plan.
- The shares were sold at prices ranging from $92.62 to $92.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $93.61 to $94.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $92.62to $93.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- Fully vested.
Billionaire Hedge Funds
